Microbiological Testing/Measurement TRIZ Cases

Cas12a replaces thermal cycling equipment by using fluorescence signals for rapid pathogen detection without expensive instrumentation.

A qPCR-based kit detects DNA methylation levels using Taq enzyme premix systems and specific primers.

A nanoscale antenna uses a nucleic acid scaffold to arrange fluorophores in a FRET cascade, directing light energy toward a central acceptor.

Engineered biological materials change state upon exposure to stimuli to detect physical tampering without power.

Segmenting diagnostic dimensions via multi-marker immunohistochemistry identifies adenoma-adenocarcinoma transitions despite genetic heterogeneity.

Analyzing discarded off-target reads during targeted-capture sequencing improves diagnostic accuracy for loss of heterozygosity events.

Genotyping polymorphic positions in intron 7 of RHD and RHCE genes enables precise discrimination between blood type variants.

Sensor DNA hybridizes with target RNA to enable polymerase-driven amplification, achieving femtomole detection limits for short sequences.

PCR detection quantifies microbial DNA in dried machine felts to distinguish biological defects from non-biological causes.

Adhesive patches collect skin surface lipids to extract nucleic acids, avoiding invasive hair removal and dedicated tapes.

Replacing transient markers with stable Axl expression data resolves detection accuracy issues and enables targeted metastatic cancer treatment.

Quantify adaptive immune response markers to improve prognosis reliability beyond clinicopathological staging.

A growth medium combining pH-sensitive fluorophors and fluorogenic substrates enables fluorescence-based microorganism detection.

CATS sequencing method generates DNA nanoballs via rolling circle replication to sequence degraded RNA with high sensitivity.

Analyzing IL-33 and ST2 expression profiles in adipose tissue detects prediabetes risk earlier than glucose tests, preventing delayed diagnosis.

A nucleic acid quantification method uses standard control samples to generate calibration curves for rapid copy number determination.

A fluidic card assembly uses a sealed chamber and serpentine microfluidic channel to deliver precise reagent volumes directly onto the biochip surface.

Segmenting genomic regions improves methylation coverage and sensitivity for advanced adenoma detection despite high background noise.

Constructing fetal genetic maps from maternal plasma DNA fragments identifies de novo mutations without prior parental genome knowledge.

Optimized primer concentrations and thermal cycling resolve allele identification accuracy versus high-throughput capability in newborn screening.

Detecting methylated genomic DNA in biological samples enables early colorectal cancer diagnosis through non-invasive liquid biopsy methods.

A nucleic acid chip detects bladder cancer methylation markers in urine samples using specific probes.

Screening IL-4Rα, IL-13, and CD14 variants predicts food allergy risk without invasive challenges.

Gene expression analysis identifies renal dysfunction via specific biomarkers, enabling early detection and accurate treatment monitoring for canines.

A recombinant bacteriophage carrying a luciferase indicator gene detects microorganisms within hours, eliminating the need for slow enrichment cultures.

Antibodies bind roundworm antigens to distinguish them from hookworm and heartworm, resolving low diagnostic specificity.

Genotyping bulk tank milk DNA estimates individual somatic cell counts, enabling early subclinical mastitis detection without costly individual sampling.

Droplet partitioning isolates cross-linked DNA fragments to detect proximal sequence elements within individual compartments.

Transposome complexes tag polynucleotides to boost yield while reducing starting material requirements.

Segmented microfluidic channels allow parallel antibiotic exposure, reducing processing time while maintaining measurement precision.

Real-time polymerase chain reaction with FRET probes identifies the epidemic BI/NAP1/027 strain, resolving sensitivity and specificity limitations.

Quantifying Akkermansia bacteria overcomes primary resistance to PD-1 inhibitors by identifying patients needing bacterial compensation.

Fluorescent viral particles replace complex infectivity assays to reduce evaluation time and cost while maintaining clearance demonstration reliability.

RT-PCR analysis of ABCD3 levels identifies metastatic potential, resolving the trade-off between diagnostic precision and unnecessary treatment side effects.

Engineering SCARECROW promoter cis-elements enables root nodule formation in non-legumes, reducing chemical fertilizer reliance.

Segmented pixels with photonic structures reduce cross-talk between sites, increasing sequencing throughput and accuracy.

Gene detection devices identify infarction types via biological samples, resolving visual ambiguity in acute treatment.

High-throughput SNP markers enable fine mapping of quantitative trait loci in canola, resolving complex inheritance barriers to reduce fiber content.

Designing probes for conserved flanking regions eliminates secondary polymorphism interference, reducing false negatives in nucleic acid detection.

Pooling DNA samples and performing simultaneous hybridization reduces per-sample costs while maintaining high-throughput genotyping capability.

Segmenting regulatory regions into V-plots improves prediction accuracy of neoplasia and inflammation without increasing computational complexity.

Segmented hairpin probes with helper oligonucleotides accelerate hybridization kinetics to achieve 100% signal in 8 minutes.

Biomarkers detect chemoradioresistant cervical cancer subtypes through specific gene dosage and expression analysis.

Co-emulsifier formulations reduce input energy requirements, enabling high-throughput nucleic acid amplification without specialized machines.

Gold nanoprobe detection eliminates expensive fluorescence equipment and reduces analysis time through visible color shifts measured by silicon sensors.

A barcoded enzyme method uses mass spectrometry to identify substrate specificity and quantify enzymatic activity through peptide barcode cleavage.

Segmenting template nucleic acid molecules with barcodes overcomes short-read length limits while maintaining high accuracy for variant identification.

Cleavable oligonucleotides enable monoclonal nucleic acid clustering on solid supports through controlled hybridization and extension cycles.